Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
2,673,800
-
Total 13F shares
-
508,154
-
Share change
-
-10,359
-
Total reported value
-
$297,499
-
Price per share
-
$0.58
-
Number of holders
-
10
-
Value change
-
-$7,049
-
Number of buys
-
8
-
Number of sells
-
2
Institutional Holders of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) as of Q2 2025
As of 30 Jun 2025,
Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
508,154 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, UBS Group AG, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, JONES FINANCIAL COMPANIES LLLP, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., CITIGROUP INC, and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.